Aion Therapeutic Inc.
AION
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.61% | 93.19% | -1,321.58% | -109.51% | 45.76% |
| Total Depreciation and Amortization | 0.00% | 4.50% | 80.18% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.93% | -98.95% | 10,182.49% | 64.65% | -16.67% |
| Change in Net Operating Assets | 234.44% | 32.73% | -167.00% | 418.30% | 81.78% |
| Cash from Operations | 72.71% | 33.23% | -430.80% | 657.89% | 81.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 88.33% | -204.94% |
| Cash from Investing | -- | -- | 100.00% | 88.33% | -204.94% |
| Total Debt Issued | -100.00% | -- | -100.00% | -- | -- |
| Total Debt Repaid | -257.14% | -123.19% | -69.67% | -- | -- |
| Issuance of Common Stock | 21.00% | -63.64% | -- | -100.00% | 150.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -101.16% | -- | -- |
| Cash from Financing | -86.43% | 6.62% | 979.78% | -87.35% | 145.61% |
| Foreign Exchange rate Adjustments | 833.33% | -1,100.00% | -101.18% | 145.74% | -196.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.09% | 104.44% | -180.23% | 1,161.73% | -196.43% |
